Eptifibatide Injection has obtained marketing authorization from the Therapeutic Goods Administration (TGA) of Australia. Product detail The name of the drug: Eptifibatide Injection Dosage form: Steril...
Contact
Tel: 0+86-898-6855-7717
Fax: +86-898-6865-2226
Email: vivian. chen@hnsp.com
News
-
Eptifibatide Injection has obtained marketing authorization from the Therapeutic Goods Administration -
Bivalirudin for Injection has obtained marketing authorization from the Therapeutic Goods Administrat
Bivalirudin for Injection has obtained marketing authorization from the Therapeutic Goods Administration (TGA) of Australia. Hainan Shuangcheng Pharmaceuticals Co. Ltd (the company) received the notifi...
-
Hainan Shuangcheng Pharmaceuticals Co. Ltd (the “company”) received the notification from the U.S
Hainan Shuangcheng Pharmaceuticals Co. Ltd (the company) received the notification from the U.S. FDA that the ANDA (abbreviated new drug application) of Paclitaxel (Albumin bound) for injection submitt...
-
The Launch Ceremony for the First Shipment of Shuangcheng Pharmaceutical's Paclitaxel (Albumin-bound)
The Launch Ceremony for the First Shipment of Shuangcheng Pharmaceuticals Paclitaxel (Albumin-bound) for Injection to the U.S. Was Successfully Held. After nine years of dormant preparation like a drag...
-
Memantine Hydrochloride Tablets Receives US FDA MA approval
News Memantine Hydrochloride Tablets Receives US FDA MA approval 2020.04.07 Ningbo Shuangcheng Pharmaceutical Co., Ltd. (Ningbo Shuangcheng), a holding subsidiary of Hainan Shuangcheng Pharmaceutical C...
